Literature DB >> 28855716

A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease.

Jae-Jung Kim1, Sin Weon Yun2, Jeong Jin Yu3, Kyung Lim Yoon4, Kyung-Yil Lee5, Hong-Ryang Kil6, Gi Beom Kim7, Myung-Ki Han8, Min Seob Song9, Hyoung Doo Lee10, Kee Soo Ha11, Sejung Sohn12, Todd A Johnson13, Atsushi Takahashi14,15, Michiaki Kubo16, Tatsuhiko Tsunoda13,17, Kaoru Ito18, Yoshihiro Onouchi18,19, Young Mi Hong12, Gi Young Jang11, Jong-Keuk Lee1.   

Abstract

Kawasaki disease (KD), a systemic vasculitis of infants and children, manifests as fever and mucocutaneous inflammation. Although its etiology is largely unknown, the epidemiological data suggest that genetic factors are important in KD susceptibility. To identify genetic variants influencing KD susceptibility, we performed a genome-wide association study (GWAS) and replication study using a total of 915 children with KD and 4553 controls in the Korean population. Six single-nucleotide polymorphisms (SNPs) in three loci were associated significantly with KD susceptibility (P<1.0 × 10-5), including the previously reported BLK locus (rs6993775, odds ratio (OR)=1.52, P=2.52 × 10-11). The other two loci were newly identified: NMNAT2 on chromosome 1q25.3 (rs2078087, OR=1.33, P=1.15 × 10-6) and the human leukocyte antigen (HLA) region on chromosome 6p21.3 (HLA-C, HLA-B, MICA and HCP5) (rs9380242, rs9378199, rs9266669 and rs6938467; OR=1.33-1.51, P=8.93 × 10-6 to 5.24 × 10-8). Additionally, SNP rs17280682 in NLRP14 was associated significantly with KD with a family history (18 cases vs 4553 controls, OR=6.76, P=5.46 × 10-6). These results provide new insights into the pathogenesis and pathophysiology of KD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28855716     DOI: 10.1038/jhg.2017.87

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  44 in total

1.  Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.

Authors:  Chiea Chuen Khor; Sonia Davila; Willemijn B Breunis; Yi-Ching Lee; Chisato Shimizu; Victoria J Wright; Rae S M Yeung; Dennis E K Tan; Kar Seng Sim; Jie Jin Wang; Tien Yin Wong; Junxiong Pang; Paul Mitchell; Rolando Cimaz; Nagib Dahdah; Yiu-Fai Cheung; Guo-Ying Huang; Wanling Yang; In-Sook Park; Jong-Keuk Lee; Jer-Yuarn Wu; Michael Levin; Jane C Burns; David Burgner; Taco W Kuijpers; Martin L Hibberd
Journal:  Nat Genet       Date:  2011-11-13       Impact factor: 38.330

2.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

3.  HLA antigens in Kawasaki disease.

Authors:  S Kato; M Kimura; K Tsuji; S Kusakawa; T Asai; T Juji; T Kawasaki
Journal:  Pediatrics       Date:  1978-02       Impact factor: 7.124

4.  Genetic susceptibility to Kawasaki disease: analysis of pattern recognition receptor genes.

Authors:  Sagano Onoyama; Kenji Ihara; Yui Yamaguchi; Kazuyuki Ikeda; Kenichiro Yamaguchi; Kenichiro Yamamura; Takayuki Hoshina; Yumi Mizuno; Toshiro Hara
Journal:  Hum Immunol       Date:  2012-04-13       Impact factor: 2.850

5.  Polymorphism of transmembrane region of MICA gene and Kawasaki disease.

Authors:  Y Huang; Y J Lee; M R Chen; C H Hsu; S P Lin; T C Sung; S C Chang; J G Chang
Journal:  Exp Clin Immunogenet       Date:  2000

6.  Kawasaki syndrome in Hawaii.

Authors:  Robert C Holman; Aaron T Curns; Ermias D Belay; Claudia A Steiner; Paul V Effler; Krista L Yorita; Jill Miyamura; Susan Forbes; Lawrence B Schonberger; Marian Melish
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

7.  Inositol-Triphosphate 3-Kinase C Mediates Inflammasome Activation and Treatment Response in Kawasaki Disease.

Authors:  Martin Prince Alphonse; Trang T Duong; Chisato Shumitzu; Truong Long Hoang; Brian W McCrindle; Alessandra Franco; Stéphane Schurmans; Dana J Philpott; Martin L Hibberd; Jane Burns; Taco W Kuijpers; Rae S M Yeung
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

8.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

9.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.

Authors:  K Durongpisitkul; V J Gururaj; J M Park; C F Martin
Journal:  Pediatrics       Date:  1995-12       Impact factor: 7.124

10.  Kawasaki disease may be a hyperimmune reaction of genetically susceptible children to variants of normal environmental flora.

Authors:  Kyung-Yil Lee; Ji-Whan Han; Joon-Sung Lee
Journal:  Med Hypotheses       Date:  2007-03-06       Impact factor: 1.538

View more
  14 in total

Review 1.  Molecular mechanisms of long non-coding RNAs in anaplastic thyroid cancer: a systematic review.

Authors:  Hilda Samimi; Sayed Mahmoud Sajjadi-Jazi; Soroush Seifirad; Rasha Atlasi; Habibollah Mahmoodzadeh; Mohammad Ali Faghihi; Vahid Haghpanah
Journal:  Cancer Cell Int       Date:  2020-07-29       Impact factor: 5.722

Review 2.  Leveraging Genetic Findings for Precision Medicine in Vasculitis.

Authors:  Marialbert Acosta-Herrera; Miguel A González-Gay; Javier Martín; Ana Márquez
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 3.  Vasculitis Pathogenesis: Can We Talk About Precision Medicine?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Front Immunol       Date:  2018-08-14       Impact factor: 7.561

Review 4.  Long Noncoding RNA HCP5, a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations.

Authors:  Jerzy K Kulski
Journal:  Cells       Date:  2019-05-20       Impact factor: 6.600

Review 5.  Current State of Precision Medicine in Primary Systemic Vasculitides.

Authors:  Erkan Demirkaya; Zehra Serap Arici; Micol Romano; Roberta Audrey Berard; Ivona Aksentijevich
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

Review 6.  Bioinformatic HLA Studies in the Context of SARS-CoV-2 Pandemic and Review on Association of HLA Alleles with Preexisting Medical Conditions.

Authors:  Mina Mobini Kesheh; Sara Shavandi; Parastoo Hosseini; Rezvan Kakavand-Ghalehnoei; Hossein Keyvani
Journal:  Biomed Res Int       Date:  2021-05-28       Impact factor: 3.411

7.  Validation of genome-wide associated variants for Kawasaki disease in a Taiwanese case-control sample.

Authors:  Ming-Ren Chen; Tzu-Yang Chang; Nan-Chang Chiu; Hsin Chi; Kuender D Yang; Lung Chang; Daniel Tsung-Ning Huang; Fu-Yuan Huang; Ya-Ping Lien; Wen-Shan Lin; Chiung-Ling Lin; Luan-Yin Chang; Yann-Jinn Lee
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

8.  Identification of LEF1 as a Susceptibility Locus for Kawasaki Disease in Patients Younger than 6 Months of Age.

Authors:  Hea-Ji Kim; Sin Weon Yun; Jeong Jin Yu; Kyung Lim Yoon; Kyung-Yil Lee; Hong-Ryang Kil; Gi Beom Kim; Myung-Ki Han; Min Seob Song; Hyoung Doo Lee; Kee Soo Ha; Sejung Sohn; Ryota Ebata; Hiromichi Hamada; Hiroyuki Suzuki; Yoichiro Kamatani; Michiaki Kubo; Kaoru Ito; Yoshihiro Onouchi; Young Mi Hong; Gi Young Jang; Jong-Keuk Lee
Journal:  Genomics Inform       Date:  2018-06-30

Review 9.  Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: An overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease.

Authors:  Bin Tang; Hang Hong Lo; Cheng Lei; Ka In U; Wen-Luan Wendy Hsiao; Xiaoling Guo; Jun Bai; Vincent Kam-Wai Wong; Betty Yuen-Kwan Law
Journal:  Phytomedicine       Date:  2020-03-18       Impact factor: 5.340

10.  Association of an IGHV3-66 gene variant with Kawasaki disease.

Authors:  Todd A Johnson; Yoichi Mashimo; Jer-Yuarn Wu; Dankyu Yoon; Akira Hata; Michiaki Kubo; Atsushi Takahashi; Tatsuhiko Tsunoda; Kouichi Ozaki; Toshihiro Tanaka; Kaoru Ito; Hiroyuki Suzuki; Hiromichi Hamada; Tohru Kobayashi; Toshiro Hara; Chien-Hsiun Chen; Yi-Ching Lee; Yi-Min Liu; Li-Ching Chang; Chun-Ping Chang; Young-Mi Hong; Gi-Young Jang; Sin-Weon Yun; Jeong-Jin Yu; Kyung-Yil Lee; Jae-Jung Kim; Taesung Park; Jong-Keuk Lee; Yuan-Tsong Chen; Yoshihiro Onouchi
Journal:  J Hum Genet       Date:  2020-10-26       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.